Physician profile
Matthew L Oldroyd
NPI 1306855408
$2,025.38
in general payments reported to CMS, 2019-2025
18 companies · $857 in 2025
The $857 reported for 2025 was more than what 93% of Anesthesiology providers received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $152 · 2020: $168 · 2021: $67.63 · 2022: $256 · 2023: $279 · 2024: $246 · 2025: $857.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,358 · Education: $24.01.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,358.20 |
| Education | $24.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nevro Corp. | $391.19 | 2019-2024 | Senza |
| Abbott Laboratories | $286.52 | 2021-2025 | Eterna |
| Spr Therapeutics, INC | $199.06 | 2024-2025 | Sprint Pns System |
| Mml US, INC. | $194.44 | 2025 | Reactiv8 |
| Relievant Medsystems, INC. | $154.43 | 2020 | |
| Vertos Medical, INC. | $144.54 | 2019-2023 | Mild Device Kit |
| Globus Medical, INC. | $142.67 | 2025 | Senza |
| Stryker Corporation | $115.21 | 2025 | Mild Device Kit |
| Merck Sharp & Dohme LLC | $112.98 | 2019-2024 | Bridion |
| Medtronic, INC. | $63.13 | 2021-2025 | Inceptiv |
| Collegium Pharmaceutical, INC. | $60.13 | 2023-2025 | Belbuca |
| Stimwave Technologies Incorporated | $43.82 | 2022 | |
| Valinor Pharma, LLC | $24.87 | 2025 | Movantik |
| Curonix LLC | $24.01 | 2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Edwards Lifesciences Corporation | $23.74 | 2022 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nalu Medical, INC. | $15.31 | 2023 | Nalu Neurostimulation System |
| Chiesi USA, INC. | $14.77 | 2021 | |
| Boston Scientific Corporation | $14.56 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Oldroyd listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.